Elsevier

Blood Reviews

Volume 10, Issue 2, June 1996, Pages 111-127
Blood Reviews

B7-mediated costimulation and the immune response

https://doi.org/10.1016/S0268-960X(96)90040-5Get rights and content

Abstract

In addition to presentation of antigen, T cells require additional or ‘costimulatory’ signals from antigen-presenting cells. Failure to receive costimulation following antigen presentation renders T cells anergic, and these cells are functionally incapable of proliferating or secreting cytokines in response to subsequent rechallenge. Recent evidence has demonstrated that a critical costimulatory signal is delivered by members of the B7 family. B7-1 (CD80) and B7-2 (CD86) provide costimulation through CD28, their ligand on the T cell. Dysregulation of expression of B7 may be implicated in the pathogenesis of autoimmune disease. In contrast, lack of expression of B7 on tumor cells may explain in part the lack of immune response against the majority of tumors. It may now be possible to exploit this pathway to induce immunological response against tumors. Blockade of this pathway will likely have significant impact on transplantation biology, to induce T-cell anergy and prevent graft rejection and graft-versus-host disease.

References (107)

  • D.M. Harlan et al.

    Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion

    Clin Immunol Immunopathol

    (1995)
  • J.C. Simon et al.

    Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin disease

    J Invest Dermatol

    (1994)
  • B. Nickoloff et al.

    T Lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28

    Blood

    (1994)
  • S.D. Miller et al.

    Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

    Immunity

    (1995)
  • V.K. Kuchroo et al.

    B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

    Cell

    (1995)
  • Y.K. Chou et al.

    Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis

    J Neuroimmunol

    (1992)
  • S. Ostrand-Rosenberg

    Tumor immunotherapy: the tumor cell as antigen-presenting cell

    Curr. Opin. Immunol

    (1994)
  • E.C. Guinan et al.

    The pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity

    Blood

    (1994)
  • L. Chen et al.

    Costimulation of T cells for tumor immunity

    Immunology Today

    (1993)
  • J.P. Allison et al.

    Manipulation of costimulatory signals to enhance antitumor T-cell responses

    Curr Opin Immunol

    (1995)
  • S.L. Topalian

    MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

    Curr Opin Immunol

    (1994)
  • R.H. Schwartz

    Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

    Cell

    (1992)
  • F.A. Harding et al.

    CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

    Nature

    (1992)
  • C.D. Gimmi et al.

    Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

  • D.J. Lenschow et al.

    Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g

    Science

    (1992)
  • L.A. Turka et al.

    T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

  • V.A. Boussiotis et al.

    B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

    J Exp Med

    (1993)
  • G.J. Freeman et al.

    B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells

    J Immunol

    (1989)
  • G.J. Freeman et al.

    Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

    Science

    (1993)
  • M. Azuma et al.

    B70 antigen is a second ligand for CTLA-4 and CD28

    Nature

    (1993)
  • D.N. Hart et al.

    B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation

    Immunology

    (1993)
  • L. Ding et al.

    IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression

    J Immunol

    (1993)
  • R.S. Mitra et al.

    Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10

    J Immunol

    (1995)
  • V.A. Boussiotis et al.

    Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation

  • B. Nickoloff et al.

    Discordant expression of CD28 ligands, BB1, and B7 on keratinocytes in vitro and psoriatic cells in vivo

    Am J Pathol

    (1993)
  • P.S. Linsley et al.

    Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

    J Exp Med

    (1991)
  • C.D. Gimmi et al.

    B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2

  • J.A. Gross et al.

    The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression

    J Immunol

    (1990)
  • C. Cerdan et al.

    Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation

    J Immunol

    (1992)
  • J.D. Fraser et al.

    Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28

    Mol Cell Biol

    (1992)
  • M. de Boer et al.

    Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells

    Eur J Immunol

    (1993)
  • T. Lindsten et al.

    Characterization of CTLA-4 structure and expression on human T cells

    J Immunol

    (1993)
  • C.B. Thompson et al.

    CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

  • J.E. Hutchcroft et al.

    Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins

  • A. August et al.

    CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tee family kinase ITK/EMT in the human Jurkat leukemic T-cell line

  • M. Raab et al.

    p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation

  • J.F. Brunet et al.

    A new member of the immunoglobulin superfamily — CTLA-4

    Nature

    (1987)
  • P.S. Linsley et al.

    CTLA-4 is a second receptor for the B cell activation antigen B7

    J Exp Med

    (1991)
  • K. Harper et al.

    CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location

    J Immunol

    (1991)
  • G.J. Freeman et al.

    CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production

    J Immunol

    (1992)
  • Cited by (0)

    View full text